| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 957,000 | 913,100 | 868,400 | 1,030,900 | | Cost of Revenue | 504,300 | 501,800 | 488,600 | 579,000 | | | Gross Profit | 452,700 | 411,300 | 379,800 | 451,900 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 318,500 | 305,700 | 277,800 | 289,000 | | Non Recurring | 2,700 | 43,900 | 300 | 564,800 | | Others | 12,300 | 11,700 | 11,600 | 13,300 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 119,200 | 50,000 | 90,100 | (415,200) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 100 | (13,500) | 4,100 | (2,600) | | Earnings Before Interest And Taxes | 119,300 | 36,500 | 94,200 | (418,700) | | Interest Expense | 65,400 | 65,600 | 57,900 | 63,100 | | Income Before Tax | 53,900 | (29,100) | 36,300 | (481,800) | | Income Tax Expense | 24,400 | (1,800) | 11,600 | (11,900) | | Minority Interest | (4,900) |
-
|
-
| (3,500) | | | | Net Income From Continuing Ops | 24,600 | (27,300) | 24,700 | (473,400) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 24,600 | (27,300) | 24,700 | (473,400) | | Preferred Stock And Other Adjustments | 3,400 | (1,900) | (1,500) |
-
| | | Net Income Applicable To Common Shares | $28,000 | ($29,200) | $23,200 | ($473,400) |
|
1.48% Nasdaq 
Income Statement
